Anandamide is a marker of obesity and fatty liver disease Our manuscript reporting a new LC-MS/MS metabolite profiling method was published in JCI Insight. Date posted: May 5, 2017 | Author: W. Taylor Kimberly | Comments Off on Anandamide is a marker of obesity and fatty liver disease Categories:
